AI helps children with diabetes get eye exams
Part of Eyes & vision, Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an AI-based way to help check children’s eyes for signs of diabetic retinopathy (diabetes-related eye disease). It may improve how quickly and consistently eye screening is done for kids with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes and need screening for diabetic retinopathy
- If you have type 1 diabetes: you’ve had it for at least 3 years and you’re age 11 or already in puberty
- If you have type 2 diabetes: you qualify based on the diabetes diagnosis
- To be in the main (extra) group: you’re ages 8–21 and you already have a known diabetic retinopathy diagnosis
- You should not have had a diabetic eye exam in the last 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an artificial intelligence (AI) system can effectively screen for eye problems related to diabetes (retinopathy) in children. The goal is to find a faster, easier way to protect your child's vision.
This study tests whether artificial intelligence can help detect early signs of diabetes-related eye damage before vision loss happens. You'd be screened at your regular doctor visit using a new AI tool, which could catch problems earlier than usual.
This study uses artificial intelligence to check for early signs of diabetic eye disease in people who haven't had an eye exam in the past year. It aims to catch problems early and prevent vision loss.
This trial tests a new AI-powered, do-it-yourself screening system for diabetic retinopathy. It may help find early signs of eye disease in people who haven't had an eye exam in the past year.
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
This trial uses an artificial intelligence (AI) system to check for diabetic eye disease (retinopathy) during your regular doctor visit. It aims to detect problems early so you can get treatment sooner.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.